Provided by Tiger Trade Technology Pte. Ltd.

Avis Budget

111.24
+5.124.82%
Volume:271.66K
Turnover:30.08M
Market Cap:3.93B
PE:-6.20
High:112.54
Open:106.12
Low:106.12
Close:106.12
52wk High:847.70
52wk Low:85.96
Shares:35.32M
Float Shares:14.85M
Volume Ratio:0.81
T/O Rate:1.83%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-17.9408
EPS(LYR):-25.2557
ROE:5800.00%
ROA:2.70%
PB:-1.16
PE(LYR):-4.40

Loading ...

Press Release: Iovance Biotherapeutics Appoints Noah Berkowitz, M.D., Ph.D., as Chief Medical Officer

Dow Jones
·
Oct 01

Does Revenue Miss Change The Bull Case For Avis Budget Group Stock (CAR)?

Simply Wall St.
·
Oct 01

Jefferies Top Pick Might Change The Case For Investing In CAR Group (ASX:CAR)

Simply Wall St.
·
Sep 30

CAR Group (WN6) Receives a Buy from Citi

TIPRANKS
·
Sep 30

CBA Exits Substantial Holder Position in CAR Group

TIPRANKS
·
Sep 29

Top 3 Australian AI Stocks To Watch In September 2026

Simply Wall St.
·
Sep 26

Commonwealth Bank of Australia Becomes Substantial Holder in CAR Group

MT Newswires Live
·
Sep 25

Avis Budget Issues New Asset-Backed Fleet Securities

TIPRANKS
·
Sep 25

Avis Budget Group - Abrcf Issues $650 Mln of Asset-Backed Securities with Five-Year Maturity on Sept 21, 2026 - SEC Filing

THOMSON REUTERS
·
Sep 25

Avis Budget Group - Abrcf Enters Amendments to Rental Car Fleet Financing Documents for Technical Changes - SEC Filing

THOMSON REUTERS
·
Sep 25

Avis Budget AESOP Unit Issues USD 650 Million Five-Year Asset-Backed Notes Secured by US Fleet Vehicles

Reuters
·
Sep 25

Press Release: Ligand and AvenCell Therapeutics Enter Financing Agreement to Advance Pipeline of Next-Generation CAR-T Therapies for up to $47 Million

Dow Jones
·
Sep 24

Marker Therapeutics Highlights Expanded Manufacturing Support of CDMO Partner Following Formation of Kincellis Advanced Therapies

GlobeNewswire
·
Sep 22

CAR Group Director Kee Wong Retires After Eight Years on Board

TIPRANKS
·
Sep 22

CAR Group Updates Dividend Notice to Add DRP Pricing Details

TIPRANKS
·
Sep 22

CAR Group Sets FY26 DRP Share Issue Price at $23.651

TIPRANKS
·
Sep 22

Tempest Secures Exclusive Option to License Clinical-Stage CD7-Targeted Lentiviral In Vivo CAR-T Platform

GlobeNewswire
·
Sep 16

CAR Group Says Commonwealth Bank of Australia No Longer a Substantial Holder

MT Newswires Live
·
Sep 11

CBA Loses Substantial Holder Status in CAR Group

TIPRANKS
·
Sep 11

Fate Therapeutics announces clinical data from FT819 study

TIPRANKS
·
Sep 09